70 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
held positions of increasing responsibility at Pfizer, with his last position as Vice President, heading up Pfizer’s Worldwide R&D Strategic … of increasing responsibility at MedImmune, LLC, a wholly owned subsidiary of AstraZeneca, most recently as Senior Vice President R&D, Head
8-K
e0rexq xja3q6
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
EX-10.1
2xypbt3xj2
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
59y veuey
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-10.1
pvtdvhe3ltd m67
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
69lrtw2oj
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
vto1s83 jg22lc2t3z8h
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
vyb1vxrw1xkjdhrc
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
8s5zz whs
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
ggksl8 rm
7 Dec 21
Departure of Directors or Certain Officers
6:15am